NCCN 8th Annual Congress: Hematologic Malignancies™
Briana O'Donnell, Marketing Manager
On Friday, September 20, and Saturday, September 21, 2013, the National Comprehensive Cancer Network® (NCCN®) is hosting its 8th Annual Congress: Hematologic Malignancies™ at the New York Marriott Marquis in New York, New York.
This two-day congress will focus on the most up-to-date treatment recommendations, important issues, controversies, recent scientific findings, and future directions for hematologic malignancies and is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
Moderated by Andrew D. Zelenetz, MD, PhD, Memorial Sloan-Kettering Cancer Center, experts from the NCCN Member Institutions will present the latest research and NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) updates regarding molecular monitoring and management options in chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL), management of Hodgkin lymphoma, and multiple myeloma, as well as non-Hodgkin's lymphomas, including marginal zone lymphoma, B-cell malignancies, and Waldenström's Macroglobulinemia. Attendees will also have the opportunity to learn about the latest developments in supportive care, with seminars about pain, antiemesis, and the transition to palliative care.
Early bird registration is available until Friday, August 16, 2013, and registration is free for Fellows! In order to take advantage of this limited time offer, Fellows must register by August 16, 2013, as well as provide a letter from their Director stating that they are a Fellow in good standing.
For more information or to register, visit NCCN.org/hem.